Multicenter registry study on proton radiotherapy of mediastinal lymphoma
Recruiting
- Conditions
- C85.2Mediastinal (thymic) large B-cell lymphoma
- Registration Number
- DRKS00015660
- Lead Sponsor
- niversitätsklinikum Heidelberg; Abteilung für RadioOnkologie und Strahlentherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
histologically confirmed lymphoma according to WHO
- informed consent
- age = 18 years
- Existence of the need for mediastinal radiotherapy and suspected benefit of mediastinal radiotherapy by protons compared to photon irradiation (e.g., improved sparing of heart, lungs and/or mamma compared to photon irradiation)
Exclusion Criteria
- Age <18 years
- Non-consent of the patient to share his data
- Revocation of the patient for study participation
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method long-term toxicity of proton radiotherapy
- Secondary Outcome Measures
Name Time Method feasibility and efficacy for proton radiotherapy